AQST
Aquestive Therapeutics Inc
NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.10
+1.23% today
Updated 2026-04-30
Market cap
$497.94M
P/E ratio
—
P/S ratio
11.18x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$2 – $8
Volume
1.7M
Aquestive Therapeutics Inc (AQST) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.12M | $2.71M | $51.78M | $66.92M | $67.43M | $52.61M | $45.85M | $50.83M | $47.68M | $50.58M | $57.56M | $44.55M |
| Revenue growth (YoY) | — | +27.9% | +1807.4% | +29.2% | +0.8% | -22.0% | -12.8% | +10.9% | -6.2% | +6.1% | +13.8% | -22.6% |
| Cost of revenue | $1.28M | $1.62M | $16.38M | $19.82M | $20.99M | $20.36M | $12.96M | $14.99M | $19.39M | $20.83M | $17.87M | $18.55M |
| Gross profit | $841000.00 | $1.09M | $35.41M | $47.10M | $46.44M | $32.25M | $32.88M | $35.84M | $28.29M | $29.75M | $39.69M | $25.99M |
| Gross margin | 39.6% | 40.2% | 68.4% | 70.4% | 68.9% | 61.3% | 71.7% | 70.5% | 59.3% | 58.8% | 69.0% | 58.3% |
| R&D | $1.26M | $1.99M | $15.45M | $22.13M | $23.11M | $20.57M | $19.89M | $17.05M | $17.48M | $13.10M | $20.28M | $17.19M |
| SG&A | $7.37M | $11.30M | $20.80M | $25.08M | $72.26M | $64.34M | $55.89M | $53.48M | $52.88M | $31.75M | $50.18M | $79.85M |
| Operating income | $-7.79M | $-12.20M | $-847000.00 | $-113000.00 | $-48.93M | $-52.67M | $-42.89M | $-34.68M | $-42.07M | $-15.10M | $-30.77M | $-71.05M |
| Operating margin | -366.9% | -449.2% | -1.6% | -0.2% | -72.6% | -100.1% | -93.6% | -68.2% | -88.2% | -29.9% | -53.5% | -159.5% |
| EBITDA | — | — | $2.94M | $2.56M | $-50.33M | $-53.88M | $-39.15M | $-45.11M | $-39.58M | $1.18M | $-26.62M | $-70.49M |
| EBITDA margin | 0.0% | 0.0% | 5.7% | 3.8% | -74.6% | -102.4% | -85.4% | -88.8% | -83.0% | 2.3% | -46.2% | -158.2% |
| EBIT | $-7.79M | $-12.20M | $-946000.00 | $-1.24M | $-53.66M | $-56.93M | $-42.76M | $-48.08M | $-41.97M | $-163000.00 | $-27.33M | $-71.05M |
| Interest expense | $0.00 | $0.00 | $6.14M | $7.71M | $7.71M | $9.32M | $13.02M | $22.46M | $12.44M | $7.46M | $16.82M | $17.10M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.28M | $-12.75M | $-9.60M | $-8.94M | $-61.38M | $-66.25M | $-55.78M | $-70.54M | $-54.41M | $-7.87M | $-44.14M | $-83.78M |
| Net income growth (YoY) | — | -54.0% | +24.7% | +6.9% | -586.3% | -7.9% | +15.8% | -26.5% | +22.9% | +85.5% | -460.8% | -89.8% |
| Profit margin | -390.2% | -469.7% | -18.5% | -13.4% | -91.0% | -125.9% | -121.7% | -138.8% | -114.1% | -15.6% | -76.7% | -188.1% |